| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | syntaxin binding | 1.04e-06 | 87 | 122 | 7 | GO:0019905 | |
| GeneOntologyMolecularFunction | SNARE binding | 2.03e-05 | 136 | 122 | 7 | GO:0000149 | |
| GeneOntologyMolecularFunction | calcium/calmodulin-dependent protein kinase activity | 2.09e-05 | 27 | 122 | 4 | GO:0004683 | |
| GeneOntologyMolecularFunction | glutamine-fructose-6-phosphate transaminase (isomerizing) activity | 3.70e-05 | 2 | 122 | 2 | GO:0004360 | |
| GeneOntologyMolecularFunction | calmodulin binding | 8.56e-05 | 230 | 122 | 8 | GO:0005516 | |
| GeneOntologyMolecularFunction | chemokine (C-C motif) ligand 5 binding | 1.11e-04 | 3 | 122 | 2 | GO:0071791 | |
| GeneOntologyMolecularFunction | L-glutamine aminotransferase activity | 1.11e-04 | 3 | 122 | 2 | GO:0070548 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.70e-04 | 18 | 122 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 6.52e-04 | 28 | 122 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | vascular endothelial growth factor receptor activity | 7.62e-04 | 7 | 122 | 2 | GO:0005021 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 7.91e-04 | 118 | 122 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 8.91e-04 | 70 | 122 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | DNHD1 MYO5A ZGRF1 ABCC5 RFC3 ABCA8 ATAD3B KIF19 KIFC3 DNAH9 ATP2B4 | 1.37e-03 | 614 | 122 | 11 | GO:0140657 |
| GeneOntologyBiologicalProcess | synaptic vesicle docking | 2.29e-06 | 17 | 118 | 4 | GO:0016081 | |
| GeneOntologyBiologicalProcess | regulated exocytosis | 6.82e-06 | 291 | 118 | 10 | GO:0045055 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to plasma membrane | 8.95e-06 | 128 | 118 | 7 | GO:1903076 | |
| GeneOntologyBiologicalProcess | exocytosis | SNPH MYO5A CAMK2A SYT6 PPFIA3 CPLX4 CCR2 OTOF CTBP2 TMED10 BAIAP3 | 4.01e-05 | 434 | 118 | 11 | GO:0006887 |
| GeneOntologyBiologicalProcess | mucociliary clearance | 5.01e-05 | 13 | 118 | 3 | GO:0120197 | |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 5.08e-05 | 228 | 118 | 8 | GO:0046777 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to cell periphery | 5.80e-05 | 171 | 118 | 7 | GO:1904375 | |
| GeneOntologyBiologicalProcess | synaptic vesicle exocytosis | 8.32e-05 | 125 | 118 | 6 | GO:0016079 | |
| GeneOntologyBiologicalProcess | fructose 6-phosphate metabolic process | 9.68e-05 | 16 | 118 | 3 | GO:0006002 | |
| GeneOntologyBiologicalProcess | vesicle docking involved in exocytosis | 1.16e-04 | 44 | 118 | 4 | GO:0006904 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | DNHD1 CFAP91 MYO5A NEK10 CCDC88C TMEM232 KIF19 KIFC3 DNAH9 PRDM14 ATP2B4 | 1.25e-04 | 493 | 118 | 11 | GO:0007018 |
| GeneOntologyBiologicalProcess | cilium movement | 1.30e-04 | 261 | 118 | 8 | GO:0003341 | |
| GeneOntologyBiologicalProcess | signal release from synapse | 1.32e-04 | 195 | 118 | 7 | GO:0099643 | |
| GeneOntologyBiologicalProcess | neurotransmitter secretion | 1.32e-04 | 195 | 118 | 7 | GO:0007269 | |
| GeneOntologyBiologicalProcess | respiratory system process | 2.77e-04 | 55 | 118 | 4 | GO:0003016 | |
| GeneOntologyCellularComponent | calcium- and calmodulin-dependent protein kinase complex | 5.14e-09 | 5 | 120 | 4 | GO:0005954 | |
| GeneOntologyCellularComponent | cytoplasmic region | DNHD1 CFAP91 RIBC2 CAMK2A TOGARAM1 PPFIA3 EFHB KIF19 CTBP2 DNAH9 | 4.39e-05 | 360 | 120 | 10 | GO:0099568 |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 1.28e-04 | 45 | 120 | 4 | GO:0033017 | |
| GeneOntologyCellularComponent | axoneme | 1.95e-04 | 207 | 120 | 7 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 2.01e-04 | 208 | 120 | 7 | GO:0097014 | |
| GeneOntologyCellularComponent | cochlear hair cell ribbon synapse | 4.83e-04 | 6 | 120 | 2 | GO:0098683 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 4.95e-04 | 317 | 120 | 8 | GO:0032838 | |
| GeneOntologyCellularComponent | cilium | CEP104 DNHD1 CFAP91 MYO5A RIBC2 FSIP1 CEP295NL TOGARAM1 EFHB TMEM232 KIF19 AGBL2 DNAH9 ATP2B4 | 6.43e-04 | 898 | 120 | 14 | GO:0005929 |
| GeneOntologyCellularComponent | ribbon synapse | 8.10e-04 | 32 | 120 | 3 | GO:0097470 | |
| GeneOntologyCellularComponent | supramolecular fiber | SNPH MYO5A RIBC2 OBSCN TOGARAM1 EFHB ZNF804A RYR1 TMEM232 KIF19 KIFC3 ASB2 DCTN4 SKA1 DNAH9 ATP2B4 | 1.16e-03 | 1179 | 120 | 16 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | SNPH MYO5A RIBC2 OBSCN TOGARAM1 EFHB ZNF804A RYR1 TMEM232 KIF19 KIFC3 ASB2 DCTN4 SKA1 DNAH9 ATP2B4 | 1.24e-03 | 1187 | 120 | 16 | GO:0099081 |
| Domain | CaMKII_AD | 1.62e-09 | 4 | 120 | 4 | PF08332 | |
| Domain | Ca/CaM-dep_prot_kinase-assoc | 1.62e-09 | 4 | 120 | 4 | IPR013543 | |
| Domain | - | 1.11e-06 | 13 | 120 | 4 | 3.10.450.50 | |
| Domain | NTF2-like_dom | 2.09e-06 | 15 | 120 | 4 | IPR032710 | |
| Domain | GATASE_TYPE_2 | 2.56e-06 | 5 | 120 | 3 | PS51278 | |
| Domain | GATase_2_dom | 2.56e-06 | 5 | 120 | 3 | IPR017932 | |
| Domain | GlmS_trans | 4.09e-05 | 2 | 120 | 2 | IPR005855 | |
| Domain | SIS | 4.09e-05 | 2 | 120 | 2 | PF01380 | |
| Domain | Chemokine_CCR5 | 4.09e-05 | 2 | 120 | 2 | IPR002240 | |
| Domain | DH_1 | 5.26e-05 | 63 | 120 | 5 | PS00741 | |
| Domain | RhoGEF | 7.60e-05 | 68 | 120 | 5 | SM00325 | |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 8.15e-05 | 69 | 120 | 5 | IPR020636 | |
| Domain | RhoGEF | 8.73e-05 | 70 | 120 | 5 | PF00621 | |
| Domain | DH_2 | 8.73e-05 | 70 | 120 | 5 | PS50010 | |
| Domain | - | 9.34e-05 | 71 | 120 | 5 | 1.20.900.10 | |
| Domain | DH-domain | 9.34e-05 | 71 | 120 | 5 | IPR000219 | |
| Domain | GDS_CDC24_CS | 1.12e-04 | 39 | 120 | 4 | IPR001331 | |
| Domain | SIS | 1.22e-04 | 3 | 120 | 2 | PS51464 | |
| Domain | SIS | 1.22e-04 | 3 | 120 | 2 | IPR001347 | |
| Domain | - | 4.74e-04 | 24 | 120 | 3 | 3.60.20.10 | |
| Domain | PROTEIN_KINASE_ATP | FLT1 FLT4 NEK10 CAMK2A CAMK2B CAMK2D CAMK2G OBSCN WNK1 MAP3K4 | 7.61e-04 | 459 | 120 | 10 | PS00107 |
| Domain | Protein_kinase_ATP_BS | 7.66e-04 | 379 | 120 | 9 | IPR017441 | |
| Domain | Tyr_kinase_rcpt_3_CS | 1.12e-03 | 8 | 120 | 2 | IPR001824 | |
| Domain | RECEPTOR_TYR_KIN_III | 1.12e-03 | 8 | 120 | 2 | PS00240 | |
| Domain | Ntn_hydrolases_N | 1.23e-03 | 33 | 120 | 3 | IPR029055 | |
| Domain | Prot_kinase_dom | FLT1 FLT4 NEK10 CAMK2A CAMK2B CAMK2D CAMK2G OBSCN WNK1 MAP3K4 | 1.23e-03 | 489 | 120 | 10 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | FLT1 FLT4 NEK10 CAMK2A CAMK2B CAMK2D CAMK2G OBSCN WNK1 MAP3K4 | 1.30e-03 | 493 | 120 | 10 | PS50011 |
| Domain | S_TKc | 2.24e-03 | 359 | 120 | 8 | SM00220 | |
| Domain | AAA | 2.38e-03 | 144 | 120 | 5 | SM00382 | |
| Domain | AAA+_ATPase | 2.38e-03 | 144 | 120 | 5 | IPR003593 | |
| Domain | Kinase-like_dom | FLT1 FLT4 NEK10 CAMK2A CAMK2B CAMK2D CAMK2G OBSCN WNK1 MAP3K4 | 2.61e-03 | 542 | 120 | 10 | IPR011009 |
| Domain | Pkinase | 3.22e-03 | 381 | 120 | 8 | PF00069 | |
| Domain | Dynein_HC_stalk | 3.54e-03 | 14 | 120 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 3.54e-03 | 14 | 120 | 2 | IPR013602 | |
| Domain | DHC_N2 | 3.54e-03 | 14 | 120 | 2 | PF08393 | |
| Domain | MT | 3.54e-03 | 14 | 120 | 2 | PF12777 | |
| Domain | PROTEIN_KINASE_TYR | 3.55e-03 | 97 | 120 | 4 | PS00109 | |
| Domain | Tyr_kinase_AS | 3.55e-03 | 97 | 120 | 4 | IPR008266 | |
| Domain | DHC_fam | 4.07e-03 | 15 | 120 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 4.07e-03 | 15 | 120 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 4.07e-03 | 15 | 120 | 2 | IPR004273 | |
| Domain | EMP24_GP25L | 4.07e-03 | 15 | 120 | 2 | PF01105 | |
| Domain | Chemokine_rcpt | 4.63e-03 | 16 | 120 | 2 | IPR000355 | |
| Pathway | REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB | 2.40e-07 | 10 | 84 | 4 | M26910 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 7.68e-07 | 54 | 84 | 6 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 7.68e-07 | 54 | 84 | 6 | MM15202 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 1.12e-06 | 14 | 84 | 4 | M47386 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 1.12e-06 | 14 | 84 | 4 | M47388 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY | 1.52e-06 | 15 | 84 | 4 | M47385 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 2.59e-06 | 103 | 84 | 7 | MM15196 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PLCG_CAMK_SIGNALING_PATHWAY | 2.63e-06 | 17 | 84 | 4 | M47387 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CAMK_SIGNALING_PATHWAY | 4.25e-06 | 19 | 84 | 4 | M47957 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 4.25e-06 | 19 | 84 | 4 | MM15473 | |
| Pathway | REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR | 5.28e-06 | 20 | 84 | 4 | M17670 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 6.50e-06 | 21 | 84 | 4 | M838 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION | 6.50e-06 | 21 | 84 | 4 | M27944 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 7.91e-06 | 22 | 84 | 4 | MM15104 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 9.53e-06 | 23 | 84 | 4 | MM14953 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP2B3_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 9.53e-06 | 23 | 84 | 4 | M47512 | |
| Pathway | REACTOME_LONG_TERM_POTENTIATION | 9.53e-06 | 23 | 84 | 4 | M27949 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.14e-05 | 24 | 84 | 4 | M47509 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.21e-05 | 130 | 84 | 7 | M27454 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.35e-05 | 25 | 84 | 4 | M47510 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.35e-05 | 25 | 84 | 4 | M47511 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.83e-05 | 55 | 84 | 5 | M971 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING | 2.15e-05 | 28 | 84 | 4 | M837 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 2.15e-05 | 28 | 84 | 4 | M47508 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 2.19e-05 | 57 | 84 | 5 | MM15643 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 2.49e-05 | 29 | 84 | 4 | MM15028 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 3.26e-05 | 31 | 84 | 4 | M7223 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 3.71e-05 | 32 | 84 | 4 | M27455 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 3.71e-05 | 32 | 84 | 4 | M27900 | |
| Pathway | REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS | 4.16e-05 | 65 | 84 | 5 | M38994 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 4.21e-05 | 33 | 84 | 4 | M39875 | |
| Pathway | REACTOME_RAF_ACTIVATION | 4.75e-05 | 34 | 84 | 4 | M27556 | |
| Pathway | REACTOME_RAF_ACTIVATION | 5.34e-05 | 35 | 84 | 4 | MM15271 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 5.34e-05 | 35 | 84 | 4 | MM15109 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 5.63e-05 | 165 | 84 | 7 | MM15026 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 6.67e-05 | 37 | 84 | 4 | M749 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 7.42e-05 | 38 | 84 | 4 | M27255 | |
| Pathway | PID_IFNG_PATHWAY | 9.10e-05 | 40 | 84 | 4 | M161 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 1.00e-04 | 41 | 84 | 4 | M512 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 1.08e-04 | 183 | 84 | 7 | M997 | |
| Pathway | REACTOME_ONCOGENIC_MAPK_SIGNALING | 1.27e-04 | 82 | 84 | 5 | M27626 | |
| Pathway | WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS | 1.33e-04 | 44 | 84 | 4 | M39845 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 1.33e-04 | 44 | 84 | 4 | M27934 | |
| Pathway | REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS | 1.45e-04 | 45 | 84 | 4 | M27623 | |
| Pathway | WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION | 1.72e-04 | 47 | 84 | 4 | M39531 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 2.05e-04 | 203 | 84 | 7 | M5485 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 2.79e-04 | 151 | 84 | 6 | M19428 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 2.96e-04 | 54 | 84 | 4 | M26911 | |
| Pathway | KEGG_MELANOGENESIS | 3.37e-04 | 101 | 84 | 5 | M7761 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 3.37e-04 | 101 | 84 | 5 | M1979 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 4.16e-04 | 59 | 84 | 4 | M11215 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY | 4.99e-04 | 110 | 84 | 5 | MM15977 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2 | 5.35e-04 | 63 | 84 | 4 | M27862 | |
| Pathway | KEGG_OOCYTE_MEIOSIS | 5.65e-04 | 113 | 84 | 5 | M16817 | |
| Pathway | WP_WNT_SIGNALING_WP428 | 5.65e-04 | 113 | 84 | 5 | M39669 | |
| Pathway | KEGG_GLIOMA | 6.02e-04 | 65 | 84 | 4 | M1835 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 6.32e-04 | 176 | 84 | 6 | MM15718 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 6.70e-04 | 178 | 84 | 6 | M2890 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 7.98e-04 | 70 | 84 | 4 | M3115 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | DAGLB CAMK2A CAMK2B CAMK2D CAMK2G WNT9B OBSCN MCF2 CCR2 CCR5 ARHGEF4 ARHGEF6 | 8.86e-04 | 702 | 84 | 12 | M746 |
| Pathway | REACTOME_SYNTHESIS_OF_UDP_N_ACETYL_GLUCOSAMINE | 9.60e-04 | 8 | 84 | 2 | M27375 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII_CAMKK_CAMKIV_CASCASDE | 9.60e-04 | 8 | 84 | 2 | M10546 | |
| Pathway | REACTOME_SYNTHESIS_OF_UDP_N_ACETYL_GLUCOSAMINE | 9.60e-04 | 8 | 84 | 2 | MM15121 | |
| Pathway | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | 9.60e-04 | 8 | 84 | 2 | M710 | |
| Pathway | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | 9.60e-04 | 8 | 84 | 2 | MM14753 | |
| Pathway | WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3 | 1.03e-03 | 75 | 84 | 4 | M39568 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 1.09e-03 | 76 | 84 | 4 | M19832 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 1.32e-03 | 80 | 84 | 4 | M800 | |
| Pathway | PID_VEGF_VEGFR_PATHWAY | 1.53e-03 | 10 | 84 | 2 | M137 | |
| Pathway | KEGG_ERBB_SIGNALING_PATHWAY | 1.79e-03 | 87 | 84 | 4 | M12467 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.84e-03 | 147 | 84 | 5 | MM15854 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 2.03e-03 | 90 | 84 | 4 | M6467 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 2.06e-03 | 151 | 84 | 5 | M39329 | |
| Pathway | WP_ERBB_SIGNALING | 2.20e-03 | 92 | 84 | 4 | M39715 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 2.20e-03 | 92 | 84 | 4 | MM14951 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 2.25e-03 | 154 | 84 | 5 | MM15974 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 2.38e-03 | 156 | 84 | 5 | M39475 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 2.38e-03 | 94 | 84 | 4 | M2843 | |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 2.67e-03 | 97 | 84 | 4 | M9400 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 2.77e-03 | 98 | 84 | 4 | M965 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 3.09e-03 | 101 | 84 | 4 | M27253 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 3.65e-03 | 52 | 84 | 3 | MM14743 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 3.81e-03 | 335 | 84 | 7 | MM14503 | |
| Pubmed | 6.62e-11 | 9 | 124 | 5 | 12660151 | ||
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 10381553 | ||
| Pubmed | Cadmium activates CaMK-II and initiates CaMK-II-dependent apoptosis in mesangial cells. | 1.54e-10 | 4 | 124 | 4 | 17367784 | |
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 11889801 | ||
| Pubmed | 7.67e-10 | 5 | 124 | 4 | 11013247 | ||
| Pubmed | 7.67e-10 | 5 | 124 | 4 | 21209221 | ||
| Pubmed | 7.67e-10 | 5 | 124 | 4 | 14722083 | ||
| Pubmed | 7.67e-10 | 5 | 124 | 4 | 18218981 | ||
| Pubmed | Transition from reversible to persistent binding of CaMKII to postsynaptic sites and NR2B. | 7.67e-10 | 5 | 124 | 4 | 16436603 | |
| Pubmed | Multiple kinases regulate mafA expression in the pancreatic beta cell line MIN6. | 2.30e-09 | 6 | 124 | 4 | 18948074 | |
| Pubmed | Motor protein-dependent transport of AMPA receptors into spines during long-term potentiation. | 4.38e-09 | 18 | 124 | 5 | 18311135 | |
| Pubmed | Rad and Rad-related GTPases interact with calmodulin and calmodulin-dependent protein kinase II. | 5.34e-09 | 7 | 124 | 4 | 9115241 | |
| Pubmed | 1.07e-08 | 8 | 124 | 4 | 11264466 | ||
| Pubmed | 1.07e-08 | 8 | 124 | 4 | 20668654 | ||
| Pubmed | 3.18e-08 | 10 | 124 | 4 | 19776387 | ||
| Pubmed | 3.18e-08 | 10 | 124 | 4 | 28361052 | ||
| Pubmed | 4.42e-08 | 3 | 124 | 3 | 9882483 | ||
| Pubmed | Identification of novel human tumor cell-specific CaMK-II variants. | 4.42e-08 | 3 | 124 | 3 | 9060999 | |
| Pubmed | 4.42e-08 | 3 | 124 | 3 | 10819240 | ||
| Pubmed | 4.42e-08 | 3 | 124 | 3 | 20844140 | ||
| Pubmed | 6.12e-08 | 147 | 124 | 8 | 16959763 | ||
| Pubmed | 7.45e-08 | 12 | 124 | 4 | 8615909 | ||
| Pubmed | 7.45e-08 | 12 | 124 | 4 | 8665664 | ||
| Pubmed | 7.45e-08 | 12 | 124 | 4 | 12815021 | ||
| Pubmed | 1.50e-07 | 14 | 124 | 4 | 10373510 | ||
| Pubmed | The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1. | 2.04e-07 | 15 | 124 | 4 | 14622581 | |
| Pubmed | 2.04e-07 | 15 | 124 | 4 | 9481670 | ||
| Pubmed | 4.40e-07 | 5 | 124 | 3 | 11160423 | ||
| Pubmed | 4.40e-07 | 5 | 124 | 3 | 19671701 | ||
| Pubmed | PTENα Modulates CaMKII Signaling and Controls Contextual Fear Memory and Spatial Learning. | 4.40e-07 | 5 | 124 | 3 | 28636948 | |
| Pubmed | 8.78e-07 | 6 | 124 | 3 | 16120608 | ||
| Pubmed | Requirement of Ca2+ and CaMKII for Stat1 Ser-727 phosphorylation in response to IFN-gamma. | 8.78e-07 | 6 | 124 | 3 | 11972023 | |
| Pubmed | 1.53e-06 | 7 | 124 | 3 | 34932950 | ||
| Pubmed | 5.21e-06 | 10 | 124 | 3 | 20124353 | ||
| Pubmed | 7.15e-06 | 11 | 124 | 3 | 21491429 | ||
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | 8.01e-06 | 372 | 124 | 9 | 22939624 | |
| Pubmed | ADAM10 hyperactivation acts on piccolo to deplete synaptic vesicle stores in Huntington's disease. | 8.52e-06 | 202 | 124 | 7 | 33601422 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PLXNA3 TMEM120B OBSCN WNK1 BIRC6 C8orf58 RYR1 CCDC88C NHSL1 PLEKHO2 RRP12 KIFC3 ARHGEF4 ZC3H7B ESPL1 | 9.74e-06 | 1105 | 124 | 15 | 35748872 |
| Pubmed | Activation of Rac GTPase by p75 is necessary for c-jun N-terminal kinase-mediated apoptosis. | 1.03e-05 | 38 | 124 | 4 | 11756498 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 15230854 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 11752157 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 24098976 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 11958683 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 15362666 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 8393164 | ||
| Pubmed | Polymorphism of CC chemokine receptors CCR2 and CCR5 in Crohn's disease. | 1.26e-05 | 2 | 124 | 2 | 11377705 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 19050266 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 12556692 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 30346478 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 32149607 | ||
| Pubmed | Polymorphism of CCR5 affecting HIV disease progression in the Japanese population. | 1.26e-05 | 2 | 124 | 2 | 11485615 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 25650780 | ||
| Pubmed | Association of CCR5-59029 A/G and CCR2-V64I variants with renal allograft survival. | 1.26e-05 | 2 | 124 | 2 | 19098363 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 22218121 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 27496951 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 23041556 | ||
| Pubmed | Two MAD tails: what the recent knockouts of Mad1 and Mxi1 tell us about the MYC/MAX/MAD network. | 1.26e-05 | 2 | 124 | 2 | 10382539 | |
| Pubmed | Alterations of L-type calcium current and cardiac function in CaMKII{delta} knockout mice. | 1.26e-05 | 2 | 124 | 2 | 20538682 | |
| Pubmed | Genetic variation at the CCR5/CCR2 gene cluster and risk of psoriasis and psoriatic arthritis. | 1.26e-05 | 2 | 124 | 2 | 20153665 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 15769362 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 18703025 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 9523577 | ||
| Pubmed | Adipocyte CAMK2 deficiency improves obesity-associated glucose intolerance. | 1.26e-05 | 2 | 124 | 2 | 34303021 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 16055130 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 12884524 | ||
| Pubmed | Effects of CCR2 and CCRS polymorphisms on HIV-1 infection in Thai females. | 1.26e-05 | 2 | 124 | 2 | 18197127 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 15213273 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 12680626 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 19824873 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 19037908 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 34908526 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 10693762 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 12837756 | ||
| Pubmed | CCR2/CCR5-mediated macrophage-smooth muscle cell crosstalk in pulmonary hypertension. | 1.26e-05 | 2 | 124 | 2 | 31320454 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 20182805 | ||
| Pubmed | The frequency of CCR5Delta32 and CCR2-64I in southern Iranian normal population. | 1.26e-05 | 2 | 124 | 2 | 15585333 | |
| Pubmed | De Novo Mutations in Protein Kinase Genes CAMK2A and CAMK2B Cause Intellectual Disability. | 1.26e-05 | 2 | 124 | 2 | 29100089 | |
| Pubmed | CaMKII is essential for the function of the enteric nervous system. | 1.26e-05 | 2 | 124 | 2 | 22952977 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 21252154 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 31619570 | ||
| Pubmed | Genetic polymorphism of chemokine receptors CCR2 and CCR5 in Swedish cervical cancer patients. | 1.26e-05 | 2 | 124 | 2 | 17094383 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 29992531 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 14981141 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 15067318 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 17361671 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 26567004 | ||
| Pubmed | Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarction. | 1.26e-05 | 2 | 124 | 2 | 11477473 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 16140745 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 21429204 | ||
| Pubmed | Adverse effect of the CCR5 promoter -2459A allele on HIV-1 disease progression. | 1.26e-05 | 2 | 124 | 2 | 11596075 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 25124496 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 12403355 | ||
| Pubmed | Chemokine receptor genotype and response to interleukin-2 therapy in HIV-1-infected individuals. | 1.26e-05 | 2 | 124 | 2 | 12584049 | |
| Pubmed | Analysis of CC chemokine receptor 5 and 2 polymorphisms and renal transplant survival. | 1.26e-05 | 2 | 124 | 2 | 16598837 | |
| Pubmed | Genotypes of CCR2 and CCR5 chemokine receptors in human myasthenia gravis. | 1.26e-05 | 2 | 124 | 2 | 14533004 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 15294044 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 21884935 | ||
| Pubmed | CCR5 haplotypes and mother-to-child HIV transmission in Malawi. | 1.26e-05 | 2 | 124 | 2 | 17786209 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 22479344 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 19517561 | ||
| Interaction | CAMK2N2 interactions | 4.71e-08 | 7 | 124 | 4 | int:CAMK2N2 | |
| Interaction | CAMK2N1 interactions | 2.79e-07 | 10 | 124 | 4 | int:CAMK2N1 | |
| Interaction | SHISA6 interactions | 6.49e-06 | 43 | 124 | 5 | int:SHISA6 | |
| Interaction | CIBAR2 interactions | 7.82e-06 | 7 | 124 | 3 | int:CIBAR2 | |
| Interaction | DSCAM interactions | 1.09e-05 | 171 | 124 | 8 | int:DSCAM | |
| Interaction | KALRN interactions | 2.83e-05 | 96 | 124 | 6 | int:KALRN | |
| Interaction | PDE4A interactions | 3.31e-05 | 30 | 124 | 4 | int:PDE4A | |
| Interaction | TULP3 interactions | 5.64e-05 | 346 | 124 | 10 | int:TULP3 | |
| Cytoband | 14q31-q32 | 7.24e-06 | 2 | 124 | 2 | 14q31-q32 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 9.55e-06 | 66 | 78 | 5 | 722 | |
| GeneFamily | Basic helix-loop-helix proteins|MAX dimerization proteins | 3.80e-04 | 7 | 78 | 2 | 637 | |
| GeneFamily | Ankyrin repeat domain containing | 6.21e-04 | 242 | 78 | 6 | 403 | |
| GeneFamily | CD molecules|C-C motif chemokine receptors | 8.09e-04 | 10 | 78 | 2 | 1091 | |
| Coexpression | GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS | CFAP91 RIBC2 NEK10 ECT2L EFHB CCDC88C TMEM232 KIF19 AGBL2 BAIAP3 DNAH9 | 1.12e-05 | 459 | 123 | 11 | M39136 |
| Coexpression | GSE15624_3H_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_UP | 1.67e-05 | 171 | 123 | 7 | M7105 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | CFAP91 NEK10 ECT2L EFHB TMEM232 KIF19 AGBL2 BAIAP3 DNAH9 SEC14L4 | 1.18e-10 | 185 | 124 | 10 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-09 | 169 | 124 | 9 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.74e-09 | 186 | 124 | 9 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.74e-09 | 186 | 124 | 9 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.96e-09 | 194 | 124 | 9 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.14e-09 | 195 | 124 | 9 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.14e-09 | 195 | 124 | 9 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.17e-09 | 200 | 124 | 9 | 52aef65f01b06cd98056f17977efe525aee6eb6f | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.17e-09 | 200 | 124 | 9 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.17e-09 | 200 | 124 | 9 | 55c148238d5c80c1faa3428a917ae8075be2c145 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 4.53e-08 | 182 | 124 | 8 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.15e-08 | 185 | 124 | 8 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.15e-08 | 185 | 124 | 8 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | Ciliated_cells-B|World / lung cells shred on cell class, cell subclass, sample id | 6.32e-08 | 190 | 124 | 8 | 7031fbedc13be1a00f6333ad6d51849c3739c2e6 | |
| ToppCell | ASK428-Epithelial-Ciliated|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.58e-08 | 191 | 124 | 8 | 0c4b926a28bc94f3cf4d68a911c0a189f6ff505e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.43e-08 | 194 | 124 | 8 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.39e-08 | 200 | 124 | 8 | 926a7ea94b5908aebf103893ea83ce9d25285b65 | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.39e-08 | 200 | 124 | 8 | 4992dbf0514d674017315dbd20d91dfec0c608e9 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.39e-08 | 200 | 124 | 8 | ddd39b754bfaa98249d497dfb7e97ec58617a11a | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.39e-08 | 200 | 124 | 8 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Ciliated|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 9.39e-08 | 200 | 124 | 8 | a521cf837cadf280505ff9d7e641a205af7d6513 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.39e-08 | 200 | 124 | 8 | 918b576fd9491d23c2bb9d663fa5fb3505cb1c7e | |
| ToppCell | Ciliated_cells-A-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 3.21e-07 | 159 | 124 | 7 | 0c65ae6140abd48c79b04758a6217709ddd15385 | |
| ToppCell | Ciliated_cells-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 6.87e-07 | 178 | 124 | 7 | 255473ee6df8a13079fb3bb61038162a40cb4c2c | |
| ToppCell | Ciliated_cells-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 8.90e-07 | 185 | 124 | 7 | 4fc7113d3dadc716ec5a8e62b58543cc00ce5b16 | |
| ToppCell | 15-Airway-Epithelial-Multiciliated_cell|Airway / Age, Tissue, Lineage and Cell class | 8.90e-07 | 185 | 124 | 7 | 0998b6bf44287eebbf39249fff23fc3689e44c4e | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 9.91e-07 | 188 | 124 | 7 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.91e-07 | 188 | 124 | 7 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.03e-06 | 189 | 124 | 7 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.03e-06 | 189 | 124 | 7 | dc440015949a768188c67661b6be63b1ead1a0f0 | |
| ToppCell | Multiciliated|World / shred by cell class for nasal brushing | 1.03e-06 | 189 | 124 | 7 | 34b110aef839376228c5a403a6b5047a945f472b | |
| ToppCell | Epithelial_cells-Ciliated_cells-B|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.06e-06 | 190 | 124 | 7 | 426a4806f6e39d4d57c6746609d30bb3ca62df7d | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.10e-06 | 191 | 124 | 7 | 2a8e6d560907e71e9f6e190ca0667da804e25641 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.10e-06 | 191 | 124 | 7 | 46c9d4d10c66c0fae1fa351924091b69ea2f38d4 | |
| ToppCell | Mild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.10e-06 | 191 | 124 | 7 | 995e76bbf07674d95b8ef09e078cf6410af27a09 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.10e-06 | 191 | 124 | 7 | a37f20172b85566b9039254a89680e37fd503fd5 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.10e-06 | 191 | 124 | 7 | 2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.14e-06 | 192 | 124 | 7 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | ASK428-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.14e-06 | 192 | 124 | 7 | 356ebddd03aec341b79890977edb8ff0804999a1 | |
| ToppCell | ASK440-Epithelial-Ciliated|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.18e-06 | 193 | 124 | 7 | a0baa8be6f590b2031fede22be588715ae458e93 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.22e-06 | 194 | 124 | 7 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.31e-06 | 196 | 124 | 7 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.31e-06 | 196 | 124 | 7 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.35e-06 | 197 | 124 | 7 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.35e-06 | 197 | 124 | 7 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.35e-06 | 197 | 124 | 7 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.40e-06 | 198 | 124 | 7 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | distal-Epithelial-Ciliated-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.45e-06 | 199 | 124 | 7 | 2de1fe124737a6cca4b3805ab3056f9d9d7c16c7 | |
| ToppCell | (10)_Ciliated|World / shred by cell type by condition | 1.50e-06 | 200 | 124 | 7 | 1b6a8025bd2746b626040058c122b1be3ab2fa61 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.50e-06 | 200 | 124 | 7 | 85c98da55f7cd4ffdf9d309b56c8cc5d43f3c04c | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.50e-06 | 200 | 124 | 7 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.50e-06 | 200 | 124 | 7 | 7cb3e3bd9e851ccb096e0a3471819471d85ebace | |
| ToppCell | (09)_Interm._secr.>cil.|World / shred by cell type by condition | 1.50e-06 | 200 | 124 | 7 | 3305e14dba12e94da42f0414fdc7a2c8caf0a183 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.50e-06 | 200 | 124 | 7 | 12bc7d95c4166d12487081a76d210b7abe5991b0 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.50e-06 | 200 | 124 | 7 | 8441e289377215a6877640946fe3f6de1f456502 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.50e-06 | 200 | 124 | 7 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.67e-06 | 154 | 124 | 6 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.67e-06 | 154 | 124 | 6 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | Ciliated_cells-A-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 6.47e-06 | 163 | 124 | 6 | 43194c6127df1ce3d29242f719645de3c11fd7c0 | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-CD45____NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-06 | 163 | 124 | 6 | a763c1632d6465a1e753bdc8eadaf819d2b09e5e | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-06 | 163 | 124 | 6 | eaed783eecd07aafa5af844b63c9d816b4da99e4 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.70e-06 | 164 | 124 | 6 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | Ciliated_cells-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 6.70e-06 | 164 | 124 | 6 | 0e9961acbb1d6c0089e6805ba6756736fa4d8bed | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-06 | 165 | 124 | 6 | e24621c8d4dbafb407033d832fe9337f13feae34 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-06 | 165 | 124 | 6 | 8741df8066a44c841752a99ad306d26ea68f5344 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.43e-06 | 167 | 124 | 6 | f33cef917fa733adf6d5a9a9e989a4d9fd462a8f | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.80e-06 | 172 | 124 | 6 | 9a1743abcd5fbd38253ea84d88ad716cfb71de36 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l12|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.39e-06 | 174 | 124 | 6 | 33e5903adb746f693433bdca11a75c508bbf50c0 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-interstitial_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.39e-06 | 174 | 124 | 6 | ca0c2f42544092848541863c4a47b334e6828b8a | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 177 | 124 | 6 | 3cb96d7d56c9ff90f1f8a6caaf49e580e2524c7d | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 178 | 124 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.07e-05 | 178 | 124 | 6 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | 15-Airway-Epithelial-Multiciliated_precursor|Airway / Age, Tissue, Lineage and Cell class | 1.07e-05 | 178 | 124 | 6 | d8e0a696bdd6af6422d72af0413f9dbd6bc02afa | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.10e-05 | 179 | 124 | 6 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.10e-05 | 179 | 124 | 6 | b7a2429d07d7146b32b3552a5f2a2542105a71e0 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.18e-05 | 181 | 124 | 6 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 1.21e-05 | 182 | 124 | 6 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | Mild/Remission-B_naive-12|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.24e-05 | 107 | 124 | 5 | 1ab09acb66e4282688fd1f6782a4009f4ea18c41 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.25e-05 | 183 | 124 | 6 | b1336eac5adbffade4cef3e0ce3de75a781ae365 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.25e-05 | 183 | 124 | 6 | cc57dcb59c68d68a546dc108dd9e009b2aab8da5 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 183 | 124 | 6 | 107cc756c45d6e92181659868d91188814dae66d | |
| ToppCell | Mild/Remission-B_naive-12|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.30e-05 | 108 | 124 | 5 | 9c25d199e7d7389c84ff32712eee7e728a4c55cc | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 1.33e-05 | 185 | 124 | 6 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.33e-05 | 185 | 124 | 6 | ed7b26bdebfd0df2b4f5020a855a052d94ae7219 | |
| ToppCell | Ciliated_cells-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.37e-05 | 186 | 124 | 6 | f72267d533fd0c5280d9741ceee3dd116300a7e4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 186 | 124 | 6 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | Ciliated_cells-B-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.41e-05 | 187 | 124 | 6 | 6fa38dbccca36bc7a4fef46de74c6688f599f421 | |
| ToppCell | normal_Lung-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 1.41e-05 | 187 | 124 | 6 | a3592f056e1c2f82ba325fea2ecc4dd6c6347c81 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.41e-05 | 187 | 124 | 6 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | 21-Trachea-Epithelial-Multiciliated_cell|Trachea / Age, Tissue, Lineage and Cell class | 1.46e-05 | 188 | 124 | 6 | 803bf76a85b3033d2a04b08dd2c03ce9c15529ba | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.46e-05 | 188 | 124 | 6 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Ciliated_cells-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.46e-05 | 188 | 124 | 6 | 606907c865bd2f11bb6474932716550f7723d858 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 1.50e-05 | 189 | 124 | 6 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | Epithelial_cells-Ciliated_cells-A|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.55e-05 | 190 | 124 | 6 | 549d813a8f23b175875e53347928941f143e236c | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.55e-05 | 190 | 124 | 6 | a90a38fccdbf75a286b4d258fc54920c02b282f7 | |
| ToppCell | Ciliated_cells-A|World / lung cells shred on cell class, cell subclass, sample id | 1.55e-05 | 190 | 124 | 6 | cd87731aaa7d252424f79cfce9f7931457f17bdf | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.59e-05 | 191 | 124 | 6 | 649fcb62ad15de2f83e61591e43923a717664ae7 | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.59e-05 | 191 | 124 | 6 | 9621e22e14ea069f22713947c9faa2d882abe5fe | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.59e-05 | 191 | 124 | 6 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.59e-05 | 191 | 124 | 6 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| Drug | Pinacidil [85371-64-8]; Down 200; 16.4uM; PC3; HT_HG-U133A | TMEM120B KDM4C PPFIA3 RFC3 ANKRD12 ARHGEF4 ZC3H7B SKA1 TTC33 | 1.44e-06 | 200 | 123 | 9 | 6356_DN |
| Drug | sunitinib | 6.90e-06 | 130 | 123 | 7 | CID005329102 | |
| Drug | HF-2035 | 9.40e-06 | 25 | 123 | 4 | CID006439511 | |
| Drug | Methimazole [60-56-0]; Down 200; 35uM; PC3; HT_HG-U133A | 9.58e-06 | 191 | 123 | 8 | 3815_DN | |
| Drug | Kn 04 | 1.11e-05 | 26 | 123 | 4 | CID000131117 | |
| Drug | Sch 37137 | 2.89e-05 | 2 | 123 | 2 | CID000197244 | |
| Drug | Lys-Nva-FMDP | 2.89e-05 | 2 | 123 | 2 | CID006475796 | |
| Drug | FMDP-Val | 2.89e-05 | 2 | 123 | 2 | CID006475745 | |
| Drug | 1-norokadaone | 3.27e-05 | 12 | 123 | 3 | CID003309928 | |
| Drug | mantATP | 3.73e-05 | 35 | 123 | 4 | CID000123756 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 4.55e-05 | 174 | 123 | 7 | 7179_UP | |
| Drug | scriptaid; Up 200; 10uM; MCF7; HT_HG-U133A | 6.48e-05 | 184 | 123 | 7 | 6901_UP | |
| Drug | proanthocyanidin | 8.65e-05 | 3 | 123 | 2 | ctd:C013221 | |
| Drug | 3-amino-3-deoxy-D-glucose | 8.65e-05 | 3 | 123 | 2 | CID000164683 | |
| Drug | 5 PA | 8.65e-05 | 3 | 123 | 2 | CID000004324 | |
| Drug | kanosamine-6-phosphate | 8.65e-05 | 3 | 123 | 2 | CID000443710 | |
| Drug | Avl-FMDP | 8.65e-05 | 3 | 123 | 2 | CID006473933 | |
| Drug | Furosemide [54-31-9]; Down 200; 12uM; MCF7; HT_HG-U133A | 8.75e-05 | 193 | 123 | 7 | 3197_DN | |
| Drug | Ethacrynic acid [58-54-8]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 8.75e-05 | 193 | 123 | 7 | 3181_DN | |
| Drug | 5211181; Up 200; 12uM; MCF7; HT_HG-U133A_EA | 9.33e-05 | 195 | 123 | 7 | 834_UP | |
| Drug | Strophanthidin [66-28-4]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 9.63e-05 | 196 | 123 | 7 | 7182_UP | |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; PC3; HT_HG-U133A | 9.63e-05 | 196 | 123 | 7 | 2119_DN | |
| Drug | Chloroquine diphosphate [50-63-5]; Up 200; 7.8uM; PC3; HT_HG-U133A | 9.63e-05 | 196 | 123 | 7 | 7251_UP | |
| Drug | Benzocaine [94-09-7]; Up 200; 24.2uM; MCF7; HT_HG-U133A | 1.06e-04 | 199 | 123 | 7 | 2822_UP | |
| Drug | Bemegride [64-65-3]; Up 200; 25.8uM; MCF7; HT_HG-U133A | 1.06e-04 | 199 | 123 | 7 | 3389_UP | |
| Drug | estradiol, USP; Down 200; 0.01uM; MCF7; HT_HG-U133A | 1.06e-04 | 199 | 123 | 7 | 5601_DN | |
| Drug | Delsoline [509-18-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.06e-04 | 199 | 123 | 7 | 6075_DN | |
| Drug | Amrinone [60719-84-8]; Down 200; 21.4uM; MCF7; HT_HG-U133A | 1.09e-04 | 200 | 123 | 7 | 3465_DN | |
| Drug | Tiabendazole [148-79-8]; Up 200; 19.8uM; PC3; HT_HG-U133A | 1.09e-04 | 200 | 123 | 7 | 4579_UP | |
| Drug | Remoxipride Hydrochloride [73220-03-8]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.09e-04 | 200 | 123 | 7 | 6503_DN | |
| Disease | heart conduction disease (implicated_via_orthology) | 9.75e-06 | 32 | 124 | 4 | DOID:10273 (implicated_via_orthology) | |
| Disease | thyroid gland carcinoma (is_marker_for) | 1.55e-05 | 12 | 124 | 3 | DOID:3963 (is_marker_for) | |
| Disease | Colorectal Carcinoma | OBSCN ABCC5 WNK1 ZNF804A ABCA8 LIG3 GSE1 SLCO1A2 PKNOX1 MTRR TSKS PDZRN4 | 4.21e-05 | 702 | 124 | 12 | C0009402 |
| Disease | posterior uveitis (is_implicated_in) | 5.24e-05 | 3 | 124 | 2 | DOID:12574 (is_implicated_in) | |
| Disease | Machado-Joseph disease (implicated_via_orthology) | 1.05e-04 | 4 | 124 | 2 | DOID:1440 (implicated_via_orthology) | |
| Disease | leiomyosarcoma (is_marker_for) | 2.60e-04 | 6 | 124 | 2 | DOID:1967 (is_marker_for) | |
| Disease | mean platelet volume | DAGLB TMEM120B MYO5A ABCC5 PFKFB4 FCHO2 TERT TRANK1 GSE1 NFE2L1 PLEKHO2 ESPL1 MXD1 | 3.71e-04 | 1020 | 124 | 13 | EFO_0004584 |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 4.14e-04 | 148 | 124 | 5 | C0279702 | |
| Disease | urticaria (is_implicated_in) | 4.82e-04 | 8 | 124 | 2 | DOID:1555 (is_implicated_in) | |
| Disease | obsolete_red blood cell distribution width | DAGLB ASNSD1 C3orf62 ABCC5 FCHO2 WNK1 BIRC6 FRMD4A NFE2L1 PDS5A ANKRD12 ZC3H7B SEC14L4 ATP2B4 MXD1 | 5.41e-04 | 1347 | 124 | 15 | EFO_0005192 |
| Disease | Coronavirus infectious disease (implicated_via_orthology) | 6.19e-04 | 9 | 124 | 2 | DOID:0080599 (implicated_via_orthology) | |
| Disease | psoriasis (is_marker_for) | 8.46e-04 | 44 | 124 | 3 | DOID:8893 (is_marker_for) | |
| Disease | response to ondansetron, QT interval | 9.40e-04 | 11 | 124 | 2 | EFO_0004682, EFO_0020997 | |
| Disease | Alzheimer disease, dementia, family history of Alzheimer’s disease | 1.09e-03 | 48 | 124 | 3 | EFO_0009268, MONDO_0001627, MONDO_0004975 | |
| Disease | Kawasaki disease (is_implicated_in) | 1.12e-03 | 12 | 124 | 2 | DOID:13378 (is_implicated_in) | |
| Disease | breast carcinoma | KDM4C NEK10 SYT6 PFKFB4 TERT ABCA8 CCDC88C FRMD4A GLG1 ZC3H7B SEC14L4 MXD1 | 1.24e-03 | 1019 | 124 | 12 | EFO_0000305 |
| Disease | platelet component distribution width | FLT4 TMEM120B ABCC5 WNK1 TRANK1 GSE1 NFE2L1 PLEKHO2 PDS5A AGBL2 | 1.35e-03 | 755 | 124 | 10 | EFO_0007984 |
| Disease | Varicose veins | 1.36e-03 | 193 | 124 | 5 | HP_0002619 | |
| Disease | plasminogen activator inhibitor 1 measurement | 1.54e-03 | 54 | 124 | 3 | EFO_0004792 | |
| Disease | Kuhnt-Junius degeneration (is_marker_for) | 1.54e-03 | 14 | 124 | 2 | DOID:10873 (is_marker_for) | |
| Disease | teratocarcinoma-derived growth factor 1 measurement | 2.02e-03 | 16 | 124 | 2 | EFO_0008297 | |
| Disease | – | 2.02e-03 | 16 | 124 | 2 | 609423 | |
| Disease | Susceptibility to HIV infection | 2.02e-03 | 16 | 124 | 2 | cv:C1836230 | |
| Disease | sarcoidosis (is_implicated_in) | 2.02e-03 | 16 | 124 | 2 | DOID:11335 (is_implicated_in) | |
| Disease | comparative body size at age 10, self-reported | 2.04e-03 | 420 | 124 | 7 | EFO_0009819 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 2.12e-03 | 128 | 124 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 2.12e-03 | 128 | 124 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 2.12e-03 | 128 | 124 | 4 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 2.12e-03 | 128 | 124 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 2.12e-03 | 128 | 124 | 4 | C0007134 | |
| Disease | plasma beta-amyloid 1-40 measurement | 2.29e-03 | 17 | 124 | 2 | EFO_0005659 | |
| Disease | cervical artery dissection | 2.29e-03 | 17 | 124 | 2 | EFO_1000059 | |
| Disease | Uterine leiomyoma, estrogen-receptor positive breast cancer | 2.56e-03 | 18 | 124 | 2 | EFO_1000649, HP_0000131 | |
| Disease | Hemangiosarcoma | 2.56e-03 | 18 | 124 | 2 | C0018923 | |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 2.86e-03 | 19 | 124 | 2 | DOID:10003 (implicated_via_orthology) | |
| Disease | chemokine (C-C motif) ligand 27 measurement | 3.23e-03 | 70 | 124 | 3 | EFO_0008082 | |
| Disease | rheumatoid arthritis, ulcerative colitis | 3.49e-03 | 21 | 124 | 2 | EFO_0000685, EFO_0000729 | |
| Disease | serum albumin measurement | 3.61e-03 | 592 | 124 | 8 | EFO_0004535 | |
| Disease | monocyte count | DAGLB FLT1 WNK1 RYR1 CCR2 GSE1 RCBTB1 GLG1 SLCO1A2 RRP12 FCRL4 ATP2B4 MXI1 | 3.74e-03 | 1320 | 124 | 13 | EFO_0005091 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RLHKQFLEEARKCLR | 601 | Q96MC4 | |
| QLQRRLVEACRKRHL | 396 | Q8N715 | |
| RERLKELLRAKLIEC | 26 | Q9NPA8 | |
| KLVRRLLKQTDECIR | 751 | Q15052 | |
| KERKHAQCLLRLVLG | 4176 | Q9NR09 | |
| KKQLVRHRLFREHCV | 366 | Q05D32 | |
| KHKVKRQRLDRICEG | 6 | P56545 | |
| KRLKEELRLHKCSTR | 976 | O94812 | |
| LAHLCRLRVRKAIGK | 596 | Q96Q27 | |
| RERLQAELDHLRKCL | 1186 | Q14687 | |
| CHLDLVRKLQELIKE | 86 | Q0JRZ9 | |
| GDTLVLRCHRRRKEK | 116 | Q96PJ5 | |
| LRCHRRRKEKLTAVK | 121 | Q96PJ5 | |
| HQLIYCKKDLLRRDV | 526 | Q9NR80 | |
| LRSCKRQVREIEKLL | 36 | Q8N302 | |
| ELLERQREKCLRKRI | 176 | Q008S8 | |
| KVKVLLNRICRRSHH | 301 | Q8NAV2 | |
| RLIKLKDNHCEQLRV | 1381 | A6QL64 | |
| AEEKHKALRLLHRCL | 441 | Q96M86 | |
| EKERLRNRNCLELKI | 1106 | Q6UB98 | |
| LKAIRDRKARLACDL | 156 | Q53RE8 | |
| LLRCRNEKKRHRAVR | 221 | P51681 | |
| IILRKCNRILDRKGE | 596 | P23634 | |
| KEKRLELIQELRTCH | 516 | Q7Z4T9 | |
| CRKRKLDTILNLERD | 671 | Q14494 | |
| CENRLKKLCQHIIKR | 451 | Q8NDN9 | |
| RFRQLLELKCKIRNH | 626 | Q6ZMN7 | |
| VKERRAHARQCLLKN | 961 | Q29RF7 | |
| RVENLQAECRKHRLL | 1621 | Q5JPF3 | |
| LHQCVRDVLRARKLR | 1956 | P23467 | |
| KNRRAHLRLCLEKLK | 66 | Q05195 | |
| LRAAVKRVLKCDVHL | 131 | O95050 | |
| RRNKRKHELLEEACR | 816 | O75145 | |
| LRKLKRRFLEEHECL | 56 | O00180 | |
| LQLEDKREHCVLLKI | 331 | Q9UBK8 | |
| HLERCCLRKLLRKLE | 156 | Q8TDN1 | |
| ERLELELTRCKEKLH | 326 | Q9P219 | |
| LNLKSVLRECDKLRH | 111 | Q5SYE7 | |
| DRDASCRKHKLRQKL | 1846 | P51805 | |
| IQLCLALRYLHKEKR | 636 | Q6ZWH5 | |
| KIRKQCALAALRDVR | 101 | Q16877 | |
| LKLKCIFCRHRVKRV | 806 | Q9H3R0 | |
| IHACLARLLKELKGR | 701 | Q8TBB1 | |
| ANDLKCIIRLIKHDL | 406 | P49916 | |
| AKRRHAELCRQKRVF | 21 | Q9H4K1 | |
| HDLVLIRLKKKGDRC | 496 | Q04756 | |
| KITLRDLKRCRMAHI | 1036 | Q06190 | |
| REKQLREHCKRLEDL | 121 | A6NF36 | |
| RKQKLALEQRCRELR | 526 | Q2TAC6 | |
| LKVHVEAKGCRRRLV | 1026 | Q5VST9 | |
| ARALLRHCKILILDE | 1341 | O15440 | |
| RCQVHLLDDRKLELL | 21 | Q9P2Q2 | |
| TLRQRLEELKKLCLR | 401 | Q9P2Q2 | |
| EAKEHRVSLKCRRQL | 791 | Q92896 | |
| KKAERACLRVHLREK | 66 | Q7Z7G2 | |
| LVRKCRERNRLITHL | 81 | Q6ZRC1 | |
| VERCRIRKLQLLAHQ | 51 | O60308 | |
| EKLHRCFRLQVESLK | 501 | Q14674 | |
| KKREDRRRLALIICN | 186 | P51878 | |
| GLKDHLKEIRRCRRL | 356 | O94808 | |
| EDLKRRILRVVAHCN | 506 | Q8NCG7 | |
| RLIKEKEEAFQRRCH | 456 | Q8IVF7 | |
| KLRRCRKELTAAIDR | 16 | Q6ZUJ4 | |
| KALERKLIFRVCALH | 791 | A8TX70 | |
| CLAELKELLRQEIHK | 676 | Q5U5Z8 | |
| LKTLLRCRNEKKRHR | 226 | P41597 | |
| IDKIRGKLRRRLCEN | 206 | Q8NFW1 | |
| FQECQRKLKHRLRLD | 611 | P10911 | |
| ELQKLRRTRICHLIR | 436 | Q9NWL6 | |
| NVLDELRHADRIKCK | 816 | Q8N7U6 | |
| RDLHNRLREIDEKLK | 376 | Q8NA03 | |
| LSRDECKRILRKLEL | 11 | Q7Z589 | |
| HRHRKELKCKTERLE | 3056 | Q9NYC9 | |
| HKHLLIKRSLRCRKC | 266 | Q9UJW0 | |
| RLERLQRKLVEPKHC | 136 | Q6IQ49 | |
| IRKRIKVCELLLHEC | 121 | Q9UDX3 | |
| HKLLSKQRRRAVVAC | 3621 | P21817 | |
| DRLLVTKCGRLRHKE | 76 | Q9NQT5 | |
| QKLEREARICRLLKH | 56 | Q13555 | |
| QKLEREARICRLLKH | 56 | Q13557 | |
| VKRHTVRDKLRLCQN | 816 | Q9HC10 | |
| LAHRLAEKSCRNLRK | 211 | P40938 | |
| KLRLFCLQLRTVDRK | 366 | P41218 | |
| RVLLNVIHECLKLRL | 621 | Q9Y6R4 | |
| LRSLKCIINLDKHRL | 201 | Q9NQ35 | |
| DRKCKLQTRVHRKTL | 276 | Q5T7P8 | |
| QKLEREARICRLLKH | 56 | Q13554 | |
| KALQKRHVCISRLVR | 206 | Q8NBS3 | |
| ENLVRIFRKKKRICH | 101 | Q6P5X7 | |
| KKFHVLLNILRHCRR | 226 | Q96BD8 | |
| LCKRSFEKRDRLRIH | 436 | Q9GZV8 | |
| DLKLTLQRCKRHASR | 56 | A0PK00 | |
| DHIKEIQRCRRLILI | 376 | Q06210 | |
| RIHLLELEKVNELCK | 126 | P55347 | |
| RRELQLRKKCHNELV | 426 | Q9BVG8 | |
| KRIETHRIRCLSKLK | 6 | P46721 | |
| RKCLLKQLERAEVRL | 381 | Q9BVR0 | |
| KLEREARICRLLKHP | 56 | Q9UQM7 | |
| QKEVCIRHLKARLKD | 81 | O15079 | |
| EKDILRCAHLQKELL | 481 | P46087 | |
| KCVRILKQFHKDLER | 81 | O43463 | |
| RLKCLLHIVRKLSAE | 836 | Q5JTH9 | |
| CAIARVRLLKLKHER | 846 | O94911 | |
| RERLVRLHFDNCVLK | 481 | Q5T9A4 | |
| RCARIFRLVLQKKHI | 361 | Q9BUI4 | |
| KLKQRLRLDVGREIC | 11 | Q9Y5W7 | |
| RKCLREEIHKDLLVT | 41 | P49755 | |
| ELLELARKIILRCKR | 66 | C9JQI7 | |
| RKCIHRDLAARNILL | 1031 | P35916 | |
| VLRHCKKRQSHLRLT | 61 | Q9HBJ7 | |
| CQRLHKKILELERQA | 491 | Q9UJT2 | |
| HAILRSENERLKKLC | 61 | Q15643 | |
| KRHLLIVGNLACLRK | 2031 | Q86YA3 | |
| CQDLRALLKRKHRFI | 71 | Q8TD55 | |
| RKDALQILHICLKRS | 196 | Q9Y4F4 | |
| LRRLRDKHLKEIQDL | 2076 | Q9H4A3 | |
| RKASIQRKLRRACLV | 2671 | O15050 | |
| HLKQCDLLKLSRRQK | 51 | O14905 | |
| RKCIHRDLAARNILL | 1016 | P17948 | |
| LCRELQRHNKTLKEE | 211 | Q9NUQ3 | |
| RRKLFGVLRLKCHSL | 971 | O14746 | |
| LHAIKRRKEILLEGC | 41 | Q6PID6 | |
| EHKCKRDILLGRLRS | 446 | Q9UGR2 | |
| RLHKLAELRKETVCA | 116 | Q7Z570 | |
| EKNRRAHLRLCLERL | 76 | P50539 | |
| LRADKLRAACIRIQK | 761 | Q9Y4I1 |